Literature DB >> 21326580

Uterine artery embolization for the treatment of adenomyosis.

Meridith J Englander1.   

Abstract

Adenomyosis is a benign uterine disorder that causes menorrhagia and dysmenorrhea. Although it was once considered a contraindication to uterine artery embolization, several authors have examined whether adenomyosis can be treated with uterine artery embolization. This article reviews the pathophysiology of adenomyosis, its imaging characteristics, as well as recent studies evaluating the efficacy of uterine artery embolization for treatment of adenomyosis.

Entities:  

Keywords:  Adenomyosis; uterine artery embolization

Year:  2008        PMID: 21326580      PMCID: PMC3036524          DOI: 10.1055/s-0028-1102994

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  39 in total

1.  A clinical failure of uterine fibroid embolization due to adenomyosis.

Authors:  S J Smith; L E Sewall; A Handelsman
Journal:  J Vasc Interv Radiol       Date:  1999-10       Impact factor: 3.464

2.  Arterial embolisation to treat uterine myomata.

Authors:  J H Ravina; D Herbreteau; N Ciraru-Vigneron; J M Bouret; E Houdart; A Aymard; J J Merland
Journal:  Lancet       Date:  1995-09-09       Impact factor: 79.321

3.  Pathological findings of uterine leiomyomas and adenomyosis following uterine artery embolization.

Authors:  Pavel Dundr; Michal Mára; Jana Masková; Zuzana Fucíková; Ctibor Povỳsil; Daniel Tvrdík
Journal:  Pathol Res Pract       Date:  2006-09-07       Impact factor: 3.250

4.  Uterine artery embolization for the treatment of uterine leiomyomata midterm results.

Authors:  S C Goodwin; B McLucas; M Lee; G Chen; R Perrella; S Vedantham; S Muir; A Lai; J W Sayre; M DeLeon
Journal:  J Vasc Interv Radiol       Date:  1999-10       Impact factor: 3.464

5.  Uterine artery embolisation for symptomatic adenomyosis--mid-term results.

Authors:  M J Bratby; W J Walker
Journal:  Eur J Radiol       Date:  2008-02-15       Impact factor: 3.528

6.  Long-term outcome of uterine artery embolization for symptomatic uterine leiomyomas.

Authors:  Paul N M Lohle; Marianne J Voogt; Jolanda De Vries; Albert J Smeets; Harry A M Vervest; Leo E H Lampmann; Peter F Boekkooi
Journal:  J Vasc Interv Radiol       Date:  2008-03       Impact factor: 3.464

7.  MRI of adenomyosis: changes with uterine artery embolization.

Authors:  Yuri Kitamura; Sandra J Allison; Reena C Jha; James B Spies; Pamela A Flick; Susan M Ascher
Journal:  AJR Am J Roentgenol       Date:  2006-03       Impact factor: 3.959

8.  Clinical significance of adenomyosis.

Authors:  V Nikkanen; R Punnonen
Journal:  Ann Chir Gynaecol       Date:  1980

9.  Uterine artery embolization for symptomatic uterine leiomyoma and adenomyosis.

Authors:  Cheng-Hong Toh; Cheng-Hesion Wu; Pei-Kwei Tsay; Kee-Min Yeow; Kuang-Tse Pan; Jeng-Hwei Tseng; Chien-Fu Hung
Journal:  J Formos Med Assoc       Date:  2003-10       Impact factor: 3.282

10.  Uterine artery embolization for symptomatic adenomyosis with or without uterine leiomyomas with the use of calibrated tris-acryl gelatin microspheres: midterm clinical and MR imaging follow-up.

Authors:  Paul N M Lohle; Jolanda De Vries; Caroline A H Klazen; Peter F Boekkooi; Harry A M Vervest; Albert J Smeets; Leo E H Lampmann; Thomas J Kroencke
Journal:  J Vasc Interv Radiol       Date:  2007-07       Impact factor: 3.464

View more
  3 in total

Review 1.  Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases.

Authors:  Mi-La Kim; Seok Ju Seong
Journal:  Obstet Gynecol Sci       Date:  2013-03-12

2.  Norethindrone acetate in the medical management of adenomyosis.

Authors:  Ozgul Muneyyirci-Delale; Ashadeep Chandrareddy; Siddhi Mankame; Nanna Osei-Tutu; Hans von Gizycki
Journal:  Pharmaceuticals (Basel)       Date:  2012-10-22

3.  Computed Tomography-Guided Superior Hypogastric Plexus Block for Secondary Dysmenorrhea in Perimenopausal Women.

Authors:  Xiaomin Yang; Jihong You; Suping Tao; Xin Zheng; Keyue Xie; Bing Huang
Journal:  Med Sci Monit       Date:  2018-07-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.